Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

CORRECTION: Theranos executives charged by SEC for 'massive fraud'

Joe Mont | March 19, 2018


In a recent post in the Filing Cabinet, we incorrectly connected a recent enforcement action against Theranos founder and CEO Elizabeth Holmes with Mylan, the maker of the EpiPen.

Any implication or connection between the two companies was incorrect. Mylan had no connection to the SEC release.

Compliance Week regrets the error.


Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.